The Cooper Companies, Inc.

The Cooper Companies, Inc.

COO
The Cooper Companies, Inc.US flagNASDAQ Global Select
53.91
USD
-0.26
- -
10.51BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.27
8.92
9.31
10.08
10.96
12.87
13.51
12.38
14.82
16.78
18.14
19.52
20.55
21.74
Basic EPS, GAAP
1.54
1.4
1.05
1.4
1.91
0.71
2.38
1.21
14.93
1.96
1.49
1.97
1.88
2.93
Free Cash Flow per Basic Share
1.24
1.13
0.77
1.83
2.39
2.42
2.14
0.9
2.66
2.28
1.09
1.44
2.18
3.48
Dividend per Share
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.02
- -
- -
- -
Book Value per Share
12.52
13.35
13.82
13.81
16.27
16.81
18.47
19.47
35.2
36.38
38.12
40.5
42.06
43.81
Tangible Book Value per Share
4.26
-0.54
0.31
0.46
1.62
-3.08
-1.05
0.45
15.7
8.52
11.19
12.29
14.29
15.81
Basic Weighted Avg Shares
192
193
193
195
195
197
196
196
197
197
198
200
199
195
Sales/Revenue/Turnover
1,588
1,718
1,797
1,967
2,139
2,533
2,653
2,431
2,922
3,308
3,593
3,895
4,092
4,237
Operating Margin (%)
21.48
17.84
13.17
16.48
20.06
16.88
19.9
12.83
17.31
15.34
14.84
18.12
16.69
12.84
Depreciation Expense
125
138
191
198
188
275
281
287
309
346
368
375
377
384
Net Income, GAAP
296
270
204
274
373
140
467
238
2,945
386
294
392
375
570
Effective Tax Rate (%)
4.92
8.33
4.83
7
5.36
57.85
2.24
10.54
- -
18.83
28.75
32.63
33.82
59.51
Profit Margin (%)
18.65
15.71
11.32
13.93
17.43
5.52
17.59
9.81
100.76
11.66
8.19
10.07
9.16
13.46
Working Capital
426
349
273
394
557
554
53
270
733
253
736
929
994
415
LT Debt
302
1,281
1,105
1,107
1,149
1,986
1,263
1,621
1,398
2,351
2,524
2,550
2,458
1,916
Total Equity
2,423
2,588
2,674
2,696
3,176
3,308
3,629
3,825
6,942
7,175
7,551
8,084
8,239
8,328
Return on Invested Capital (%)
12.12
8.34
5.63
7.49
9.72
3.73
9.6
4.93
- -
4.5
3.8
4.59
4.24
8.64
Return on Capital (%)
11.36
8.17
5.48
7.38
9.66
3.61
9.89
4.78
- -
4.71
3.68
4.52
4.12
7.54
Return on Common Equity (%)
12.88
10.85
7.77
10.21
12.7
4.32
13.46
6.4
54.7
5.47
4
5.02
4.59
6.84

Capital Structure

FRC

in mil. unless spec.
Jan'26
Apr'26
Jul'26
ST Debt
621
599
628
LT Borrowings
1,877
1,860
1,914
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
195
195
190
Market Capitalization
15,877
12,260
13,748

Working Capital

FRC

in mil. unless spec.
Jan'26
Apr'26
Jul'26
Total Current Assets
2,134
2,300
2,282
Cash, Cash Equivalents & STI
125
139
155
Accounts Receivable, Net
807
809
789
Inventories
876
896
912
Total Current Liabilities
1,596
1,805
1,867
Payables & Accruals
226
558
568
ST Debt
621
599
628
Deferred Revenue
130
128
130

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.69%
19.81%
1.92%
Free Cash Flow
32.01%
43.14%
50.54%
Net Income, GAAP
124.64%
210.69%
-4.44%
Sales/Revenue/Turnover
8.85%
11.1%
5.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
932
943
1,003
1,018
3,895
2025
965
1,002
1,060
1,065
4,092
2026
1,024
1,082
1,066
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.41
0.45
0.53
0.59
1.97
2025
0.52
0.44
0.49
0.43
1.88
2026
0.67
-0.4
2.24
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Albert G. White
Full Time Employees
15,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
6101 Bollinger Canyon Road San Ramon CA United States of America 94583
IPO Date
Jan 21, 1983
Business
The Cooper Companies, Inc. (Nasdaq: COO) develops, manufactures, and markets a broad range of medical devices focused on vision care and women's health. The company operates through two primary business units: CooperVision, which produces soft contact lenses including daily, two-week, and monthly disposables for spherical, toric, multifocal, and presbyopia correction; and CooperSurgical, which provides fertility products, genomic solutions, contraception devices, reproductive care tools, birth-related instruments, women's and family health diagnostics, office and surgical devices such as INSORB staplers, Lone Star retractors, and Doppler blood flow monitors. Products are distributed to eye care practitioners, healthcare professionals, hospitals, clinics, group purchasing organizations, and authorized resellers worldwide. Founded in 1958 and headquartered in San Ramon, California, the company employs over 16,000 people across 130 countries in Europe, Asia, Africa, and the Americas. In August 2024, CooperSurgical acquired obp Surgical for approximately $100 million, adding the ONETRAC portfolio of single-use cordless surgical retractors with integrated multi-LED lighting and smoke evacuation, as well as cordless suction devices with radial LED lights, which generated $14.5 million in trailing twelve-month revenue and complement existing surgical offerings. This acquisition, expected to be neutral to non-GAAP earnings per share in fiscal 2024 and accretive thereafter, underscores ongoing strategic expansion in women's health and surgical devices; additionally, in September 2025, the board authorized a $2 billion stock repurchase program representing up to 15.4% of outstanding shares.

Company News

  • The Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower -- HBSS

  • Nike COO Alagirisamy Venkatesh Sells 3,671 Shares

  • Cooper Companies Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cooper Companies (COO)

  • The Cooper Companies, Inc. (COO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Securities Fraud Investigation Into The Cooper Companies, Inc. (COO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Gen Digital COO Sells 28,248 Shares

  • Securities Fraud Investigation Into The Cooper Companies, Inc. (COO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Cooper Cos. Stock Drops After Soft Outlook, News It Won't Seek Deal

  • 2 Medical-Device Stocks Lighting Up the Options Pits

  • Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More

  • These Analysts Slash Their Forecasts On Cooper Companies Following Q3 Results

  • 2 Reasons Cooper Companies Stock Is By Far the Worst in the S&P 500 Today

  • TSMC, Cooper Cos., American Eagle, Oracle, and More Stocks That Explain Today's Market

  • Cooper Companies Q3 Earnings Call Highlights

  • The Cooper Companies (COO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

  • The Cooper Companies (COO) Beats Q3 Earnings Estimates

  • CooperCompanies Announces Third Quarter 2026 Results

  • CooperCompanies Completes Strategic Review, Increases Share Repurchase Authorization

  • Abercrombie & Fitch COO Scott Lipesky Sells 5,000 Shares for $745,000

  • Cooper Companies Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call